MIAMI, Feb 19, 2018—Amine Rafik, M.D., Ph.D., a member of the Global Stem Cells Group Advisory Board, will be a keynote speaker at the International Association for Stem Cell Application (ISSCA) Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Rafik will speak on the role of adipose-derived stem cells in regenerative medicine as an attractive alternative to the use of stem cells derived from bone marrow and other sources, due to their abundance in fat and their ability to be easily harvested.
Amine Rafik, M.D., Ph.D
Rafik’s lecture will include patient demographic data and digital photographs taken on the day of each patient’s surgery and every day thereafter. ASC patients received three treatments of 20 cc of autologous adipose stem cell injections in the subcutaneous tissue surrounding the ulcer with time to wound closure defined as the time at which the wound bed was completely re-epithelialized and filled with new tissue.
He will discuss study results revealing the average time for wound closure in adipose stem cell (ASC) recipient patients compared to control group patients. He will also examine the study’s conclusion that suggests local transplantation of autologous adipose stem cells could accelerate wound healing, and that some clinical aspects of wound healing, as well as the potential for therapies based on stem cells, represent a feasible therapeutic approach to the treatment of clinical wounds.
Rafik is a consultant and plastic, reconstructive and aesthetic surgeon at Al Farabi Hospital in Morocco. He specializes in reconstructive plastic surgery particularly for the face, head, and neck, as well as for patients who require reconstructive surgery following treatment for skin cancer or trauma. Rafik also performs cosmetic surgery and microsurgery.
He completed his plastic surgery training in Casablanca and was awarded full membership to the American Academy of Cosmetic Surgery in 2015, and the European Association of Maxilla-Facial surgery in 2016.
He is a reviewer for many international indexed journals, including; OncoTargets and Therapy Journal, the British Journal of Medicine and Medical Research, and the Cancer and Clinical Oncology Journal, published by Canadian Center of Science and Education, where he is a member of the editorial board.
The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.
The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.
To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today.
For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
ISSCA conference speaker Amine Rafik
